Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, Elaine, Liversidge, Gary G, Cooper, Eugene R
Published in European Journal of Pharmaceutical Sciences (01.02.2003)
Published in European Journal of Pharmaceutical Sciences (01.02.2003)
Get full text
Book Review
Journal Article
Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs
Jinno, Jun-ichi, Kamada, Naoki, Miyake, Masateru, Yamada, Keigo, Mukai, Tadashi, Odomi, Masaaki, Toguchi, Hajime, Liversidge, Gary G., Higaki, Kazutaka, Kimura, Toshikiro
Published in Journal of controlled release (10.03.2006)
Published in Journal of controlled release (10.03.2006)
Get full text
Journal Article
In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol
Jinno, Jun-ichi, Kamada, Naoki, Miyake, Masateru, Yamada, Keigo, Mukai, Tadashi, Odomi, Masaaki, Toguchi, Hajime, Liversidge, Gary G., Higaki, Kazutaka, Kimura, Toshikiro
Published in Journal of controlled release (25.08.2008)
Published in Journal of controlled release (25.08.2008)
Get full text
Journal Article
A Formulation Strategy for Gamma Secretase Inhibitor ELND006, a BCS Class II Compound: Development of a Nanosuspension Formulation with Improved Oral Bioavailability and Reduced Food Effects in Dogs
Quinn, Kevin, Gullapalli, Rampurna Prasad, Merisko-liversidge, Elaine, Goldbach, Erich, Wong, Angelina, Liversidge, Gary G., Hoffman, Wherly, Sauer, John-michael, Bullock, John, Tonn, George
Published in Journal of pharmaceutical sciences (01.04.2012)
Published in Journal of pharmaceutical sciences (01.04.2012)
Get full text
Journal Article
Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin
Merisko-Liversidge, Elaine, McGurk, Simon L, Liversidge, Gary G
Published in Pharmaceutical research (01.09.2004)
Published in Pharmaceutical research (01.09.2004)
Get full text
Journal Article